mesalamine


Also found in: Thesaurus, Medical, Legal, Financial, Encyclopedia, Wikipedia.

me·sal·a·mine

 (mə-săl′ə-mēn′)
n.
A salicylate drug derived from sulfasalazine, C7H7NO3, used primarily to treat inflammatory bowel disease.
[me(ta)- + sal(icylic acid) + amine.]
Translations

mesalamine

(USAN), mesalazine (INN) n mesalamina, mesalazina (INN)
References in periodicals archive ?
('Teva') regarding APRISO (mesalamine) extended-release capsules 0.375g.
BAUSCH HEALTH PROVIDES APRISO INTELLECTUAL PROPERTY LITIGATION UPDATE
M2 PHARMA-June 24, 2019-Rising Pharmaceuticals Launches Mesalamine Suppository
Rising Pharmaceuticals Launches Mesalamine Suppository
She was treated with prednisone and mesalamine with a partial response.
Stevens-Johnson syndrome on treatment with sulfasalazine for Crohn's disease: Need for a multidisciplinary approach
* Aminosalicylates: Sulfasalazine (Azulfidine), olsalazine (Dipentum), mesalamine (Apriso, Asacol), balsalazide (Colazol)
Controlling Symptoms of Inflammatory Bowel Disease: Many of the medications used to treat IBD target the chronic inflammation that disrupts digestive function
M2 EQUITYBITES-December 18, 2018-Mylan NV unveils Mesalamine Delayed-Release Tablets USP in 1.2 g for management of ulcerative colitis in US patients
Mylan NV unveils Mesalamine Delayed-Release Tablets USP in 1.2 g for management of ulcerative colitis in US patients
Global Banking News-December 18, 2018-Mylan NV unveils Mesalamine Delayed-Release Tablets USP in 1.2 g for management of ulcerative colitis in US patients
Mylan NV unveils Mesalamine Delayed-Release Tablets USP in 1.2 g for management of ulcerative colitis in US patients
launch of Mesalamine Rectal Suppository, 1000 mg, the first generic version of Allergan's (AGN) Canasa Rectal Suppository, 1000 mg.
Mylan announces U.S. launch of generic Canasa suppository
Last month, Zydus announced the launch of its ANDA for mesalamine 800 mg delayed-release tablets.
Zydus Pharmaceuticals
Steroids, mesalamine, and azathioprine were given to the patient.
Neonatal Presentation of Unremitting Inflammatory Bowel Disease
Enormous efforts have been made to find an effective therapy for IBD although current drugs including sulfasalazine, mesalamine, and corticosteroids taken alone or in combination contribute to decelerating disease progression [3].
Portulaca Extract Attenuates Development of Dextran Sulfate Sodium Induced Colitis in Mice through Activation of PPAR[gamma]
Patients with UC are usually prescribed mesalamine which can also cause cardiac complications.
Myocarditis Secondary to Mesalamine-Induced Cardiotoxicity in a Patient with Ulcerative Colitis
[11] Mesalamine (5-aminosalicylic acid) enema 1 g/day was added to the existing SASP therapy.
Inflammatory arthritis complicated by inflammatory bowel disease: two case reports
Dictionary browser ?
Full browser ?